Kemron

Last updated

Kemron is the name of a drug which was released in Kenya in 1991 and was alleged to be highly effective in removing the symptoms of AIDS. When put under international scrutiny, the treatment was seen to perform no better than placebo. The advent of the drug was notable for the government support and international attention it received.

Contents

Claim

In August 1990, Kenyan researcher Davy Koech, director of the Kenya Medical Research Institute, announced that when his HIV patients chewed wafers laced with tiny amounts of alpha interferon, most had greatly improved health and some cleared HIV from their blood entirely. [1] The alpha interferon, named "Kemron" for this use, was a drug used to treat cancer in much greater doses. [2]

In 1993, Professor Arthur Obel, a Kenyan scientist, claimed that Kemron and another drug called Pearl Omega could cure HIV/AIDS. Kemron was later proved to be ineffective and Pearl Omega had very few positive outcomes. Obel tested on patients with these drugs and these patients filed a lawsuit on Obel for testing unproven drugs on them. The government later denounced both drugs and Obel's reputation has been discredited. [3]

Response

After reviewing the experimental data, internationally recognized AIDS experts and health officials in the United States said that there was no merit to the claim. [2]

Kenyan president Daniel arap Moi announced that "Fifty AIDS victims have already been cured" and Koech dismissed the skepticism of Western scientists. [2] Barbara Justice, a physician in New York, claimed that 82% of AIDS patients at the Abundant Life clinic saw increases in their appetites and "other improvements." [4] Neither the World Health Organization nor the NIH found evidence that Kemron performed better than placebo. [2]

Withdrawal of claim

Support of the drug proved to be an accomplishment for many of its supporters as the drug cured patients under controlled conditions.[ citation needed ]

The University of Pretoria and the Government of South Africa ultimately were not able to support the claim of the drug's efficacy. [5]

Related Research Articles

The Duesberg hypothesis is the claim that AIDS is not caused by HIV, but, instead, that AIDS is caused by noninfectious factors such as recreational and pharmaceutical drug use and that HIV is merely a harmless passenger virus. The hypothesis was popularized by University of California, Berkeley professor Peter Duesberg, from whom the hypothesis gets its name. The scientific consensus is that the Duesberg hypothesis is incorrect and that HIV is the cause of AIDS. The most prominent supporters of the hypothesis are Duesberg himself, biochemist and vitamin proponent David Rasnick and journalist Celia Farber. The scientific community generally contends that Duesberg's arguments in favor of the hypothesis are the result of cherry-picking predominantly outdated scientific data and selectively ignoring evidence that demonstrates HIV's role in causing AIDS.

<span class="mw-page-title-main">Zidovudine</span> Antiretroviral medication

Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.

<span class="mw-page-title-main">HIV/AIDS denialism</span> False belief that HIV does not cause AIDS

HIV/AIDS denialism is the belief, despite conclusive evidence to the contrary, that human immunodeficiency virus (HIV) does not cause acquired immune deficiency syndrome (AIDS). Some of its proponents reject the existence of HIV, while others accept that HIV exists but argue that it is a harmless passenger virus and not the cause of AIDS. Insofar as they acknowledge AIDS as a real disease, they attribute it to some combination of sexual behavior, recreational drugs, malnutrition, poor sanitation, haemophilia, or the effects of the medications used to treat HIV infection (antiretrovirals).

HIV-positive people, seropositive people or people who live with HIV are people who have the human immunodeficiency virus HIV, the agent of the currently incurable disease AIDS.

Matthias Rath is a doctor, businessman, and vitamin salesman. He earned his medical degree in Germany. Rath claims that a program of nutritional supplements, including formulations that he sells, can treat or cure diabetes, cardiovascular disease, cancer, and HIV/AIDS. These claims are not supported by any reliable medical research. Rath runs the Dr. Rath Health Foundation, has been closely associated with Health Now, Inc., and founded the Dr. Rath Research Institute.

This is a timeline of HIV/AIDS, including cases before 1980.

amfAR

amfAR, the Foundation for AIDS Research, known until 2005 as the American Foundation for AIDS Research, is an international nonprofit organization dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of AIDS-related public policy.

<span class="mw-page-title-main">Joseph Sonnabend</span> South African physician (1933–2021)

Joseph Adolph Sonnabend was a South African physician, scientist and HIV/AIDS researcher, notable for pioneering community-based research, the propagation of safe sex to prevent infection, and an early multifactorial model of AIDS.

With less than 1 percent of the population estimated to be HIV-positive, Egypt is a low-HIV-prevalence country. However, between the years 2006 and 2011, HIV prevalence rates in Egypt increased tenfold. Until 2011, the average number of new cases of HIV in Egypt was 400 per year. But, in 2012 and 2013 it increased to about 600 new cases and in 2014 it reached 880 new cases per year. According to UNAIDS 2016 statistics, there are about 11,000 people currently living with HIV in Egypt. The Ministry of Health and Population reported in 2020 over 13000 Egyptians are living with HIV/AIDS. However, unsafe behaviors among most-at-risk populations and limited condom usage among the general population place Egypt at risk of a broader epidemic.

Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7. Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

Initial events and trends in the discussion of HIV and AIDS in mass media contributed to the stigma and discrimination against those affected with the disease. Later discussion, sometimes led by HIV+ individuals themselves, moved toward advocacy and education on disease prevention and management. The UNESCO report on Journalism Education says, "Well researched television content can create public awareness about HIV prevention, treatment, care and support can potentially influence the development and implementation of relevant policies."

The Academic Model Providing Access to Healthcare (AMPATH) is an academic medical partnership between North American academic health centers led by the Indiana University School of Medicine in Indianapolis, Indiana and the Moi University School of Medicine, centered in Eldoret, Kenya. It is the first food-and-drug treatment model to be established in Africa. The program seeks to provide comprehensive HIV care services through its three-way mission: care, research, and training; It currently serves 3.5 million people, with over 60 urban and rural clinics in Western Kenya.

In South Africa, HIV/AIDS denialism had a significant impact on public health policy from 1999 to 2008, during the presidency of Thabo Mbeki. Mbeki criticized the scientific consensus that HIV is the cause of AIDS beginning shortly after his election to the presidency. In 2000, he organized a Presidential Advisory Panel regarding HIV/AIDS including several scientists who denied that HIV caused AIDS.

Ombitasvir/paritaprevir/ritonavir, sold under the brand name Technivie among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ombitasvir, paritaprevir, and ritonavir. Specifically it is used together with dasabuvir or ribavirin for cases caused by hepatitis C virus genotype 1 or 4. Cure rates are around 95%. It is taken by mouth.

Thomas Charles Merigan was born January 18, 1934 in San Francisco. He is an American virologist and the George E. and Lucy Becker Professor of Medicine, Emeritus at the Stanford University School of Medicine. Merigan's research first focused on human viral pathogenesis, basic and clinical studies of interferon, and then developing the first systemically active antiviral drugs including those effectively treatIng HIV/AIDS, herpesviruses and hepatitis B. He is also credited with helping to develop the use of interferons as antiviral, immunomodulating and antitumor therapies. Merigan joined the Stanford faculty in 1963 and assumed full emeritus status in 2007. In 2004 he was also identified as one of the 250 most cited investigators in clinical medicine over the last 20 years by the Institute for Scientific Information. Merigan also was ranked 23rd among the 1000 top US microbiologists by Research.com. in 2022. He had over 95 postdoctoral fellows, students and visiting scientists with whom he published 577 papers, 24 books and published symposia, and held 11 US patents. Two of his books went into multiple editions- one into a 4th edition and the other into a 3rd. His students have become leaders in the fields of infectious diseases and microbiology both in the US and the world. Seven of his students subsequently joined the Stanford medical faculty. He was a board member of 28 journals and a member of 23 learned societies. He told his life story in a book entitled Pioneering Viral Therapy,a Life in Academic Medicine, published by Amazon/Kindle/CreateSpace in 2017.

HPA-23, sometimes known as antimonium tungstate, is an antiretroviral drug that was used for the treatment of HIV infection. It achieved widespread publicity as an effective treatment for HIV and AIDS beginning in 1984, just one year after HIV was first identified. Later testing failed to demonstrate any efficacy and some patients suffered serious side effects from the drug, including liver failure.

Professor Ravindra "Ravi" Kumar Gupta is a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge. He is also a member of the faculty of the Africa Health Research Institute in Durban, South Africa.

<span class="mw-page-title-main">Davy Kiprotich Koech</span>

Davy Kiprotich Koech is a Kenyan scientist. He is currently the Chief Executive Officer Centre for Clinical & Molecular Sciences; Professor of Immunology & Molecular Medicine; Distinguished Professor, The Australian-Asian Institute of Civil Leadership.

Professor Arthur Obel, a Kenyan scientist, identified the first cases of Human Immunodeficiency Virus in Kenya and treated many AIDS patients. He developed two medications, Kemron and Pearl Omega, to cure HIV/AIDS. It was later discovered that neither Kemron nor Pearl Omega were effective medications against the retrovirus.

References

  1. ↑ Perlez, Jane (3 October 1990). "In Kenya, a New AIDS Drug Gets Mired in Politics and Financial Disputes". The New York Times . ISSN   0362-4331 . Retrieved 3 November 2011.
  2. 1 2 3 4 Hager, Mary (3 January 1993). "The Angry Politics Of Kemron". Newsweek . 121 (1): 43. Retrieved 3 November 2011.
  3. ↑ R, Dodd (1996-06-15). "Patients Sue "AIDS-cure" Kenyan Scientist". Lancet. 347 (9016): 1688. doi:10.1016/s0140-6736(96)91516-0. PMID   8642971. S2CID   25730611 . Retrieved 2020-05-29.
  4. ↑ "AIDS Work at a Nation of Islam Clinic Is Questioned". The New York Times. 4 March 1994. Retrieved 17 May 2016.
  5. ↑ "South African AIDS 'Cure' Conjures Up Kemron Myth". thepharmaletter.com. 17 February 1997. Retrieved 3 November 2011.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.